Le Lézard
Classified in: Health, Covid-19 virus
Subject: SCZ

Reducing the Spread of Coronavirus in Senior Living Communities and Nursing Homes


ATLANTA, March 5, 2020 /PRNewswire/ -- Accushield today announced the release of an updated feature that gives Senior Living and Nursing Home operators the ability to add a Coronavirus Question screen to the Accushield visitor sign-in kiosk(s) at entrances to their communities. This new kiosk screen prompts visitors to answer "Yes" or "No" to a Coronavirus question: Here is an example Coronavirus question that one community added to the visitor sign-in process: Ex: Have you traveled internationally, or have you been exposed to anyone with cold or flu symptoms in the past 30 days? "Yes" responses are then directed to see community management prior to entering the community. Note: Senior Living Community operators can customize this Coronavirus question on the kiosk to address their needs.

"Coronavirus or COVID-19 is a serious risk for seniors, especially for those living in a community environment," says Allen Barnes, CEO at Accushield, LLC.

The Coronavirus screening question feature will be available free of charge for all Accushield Partner Communities starting today. If you want more information regarding the Accushield Visitor Management System, please visit www.accushield.com or call 404.301.3101 to speak with a sales associate.

About Accushield: The Accushield Visitor Management System replaces the paper sign-in logs at the front of Assisted Living, Independent Living, Memory Care, CCRC'S, and Nursing Homes with a touchscreen, badge printing Kiosk that signs-in families and friends, third-party healthcare providers, and vendors.

Related Images

reducing-the-risk-of-a-coronavirus.png
Reducing the Risk of a Coronavirus Outbreak in Senior Living and Nursing Homes
Senior Living and Nursing Homes operators the ability to add a Coronavirus Question screen to the Accushield visitor sign-in kiosk(s) at entrances to their communities

SOURCE Accushield, LLC


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: